The evolution of oral biologic delivery – a Lonza Capsugel podcast episode

Capsugel®/ Lonza published a new podcast episode:

For years, oral delivery of biologics has been viewed as impractical. But what if the issue is not the route, but the approach?

In their new podcast episode , Lonza Capsugel’s Vincent Jannin, R&D expert, discusses how using strategies that work with gastrointestinal physiology, rather than fighting against it, opens new possibilities for clinically and commercially viable oral dosage forms.

From peptides to emerging modalities, the conversation challenges long-standing assumptions and highlights how integrated capsule and formulation technologies are redefining what is possible.

Listen to the full discussion and discover how we’re turning oral biologics into strategic opportunity.

* The presented information was correct and current at the time of publication.

Continue reading and listening the original here

Source: Capsugel®/ Lonza, website The evolution of oral biologic delivery | Capsugel

Enjoy our recorded webinar:

Lipid-based formulations and enteric capsules to enhance oral bioavailability of peptides

Interested in more information about Capsugel®/Lonza capsules?